Robinswood Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.6K Hold
81
0.03% 114
2026
Q1
$74.7K Hold
81
0.02% 121
2025
Q4
$87.2K Hold
81
0.03% 112
2025
Q3
$61.8K Hold
81
0.02% 126
2025
Q2
$63.1K Hold
81
0.02% 128
2025
Q1
$66.9K Buy
+81
New +$67.4K 0.02% 112
2024
Q4
Sell
-5
Closed -$4.43K 356
2024
Q3
$4.43K Hold
5
﹤0.01% 271
2024
Q2
$4.53K Buy
5
+2
+67% +$1.6K ﹤0.01% 268
2024
Q1
$2.29K Buy
+3
New +$2.13K ﹤0.01% 212

Other funds holding LLY

Robinswood Financial's LLY Position: Q2 2026 in Review

Robinswood Financial held its Eli Lilly (LLY) position steady in Q2 2026 at 81 shares worth $97.6K. The position accounts for 0.03% of the portfolio, ranked #114.

Robinswood Financial first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Robinswood Financial held 81 shares of Eli Lilly worth $97.6K as of Q2 2026.
  • Robinswood Financial left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.03% of Robinswood Financial's portfolio in Q2 2026, its #114 holding.
  • Robinswood Financial first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.